These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23159155)

  • 21. P53 and Murine Double Mimute 2 (MDM2) Expression Changes and Significance in Different Types of Endometrial Lesions.
    Jiang Z; Xu W; Dan G; Liu Y; Xiong J
    Med Sci Monit; 2016 Dec; 22():4786-4793. PubMed ID: 27924072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between p53 expression and gastric cancers in cardia and antrum.
    Azarhoush R; Keshtkar AA; Amiriani T; Kazemi-Nejad V
    Arch Iran Med; 2008 Sep; 11(5):502-6. PubMed ID: 18759514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of C/EBP homologous protein (CHOP) expression in gastric cardia adenocarcinoma: Their relationship with clinicopathological parameters and prognostic significance.
    Zhu XJ; Gao SG; Li SQ; Shi ZG; Ma ZK; Zhu SS; Feng XS
    Clin Res Hepatol Gastroenterol; 2015 Jun; 39(3):391-8. PubMed ID: 25582300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mdm2 gene amplification in gastric cancer correlation with expression of Mdm2 protein and p53 alterations.
    Günther T; Schneider-Stock R; Häckel C; Kasper HU; Pross M; Hackelsberger A; Lippert H; Roessner A
    Mod Pathol; 2000 Jun; 13(6):621-6. PubMed ID: 10874665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
    Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD
    Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promoter hypermethylation-mediated downregulation of miR-770 and its host gene MEG3, a long non-coding RNA, in the development of gastric cardia adenocarcinoma.
    Guo W; Dong Z; Liu S; Qiao Y; Kuang G; Guo Y; Shen S; Liang J
    Mol Carcinog; 2017 Aug; 56(8):1924-1934. PubMed ID: 28345805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas.
    Fléjou JF; Muzeau F; Potet F; Lepelletier F; Fékété F; Hénin D
    Pathol Res Pract; 1994 Dec; 190(12):1141-8. PubMed ID: 7540752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysfunction of p53 pathway in human colorectal cancer: analysis of p53 gene mutation and the expression of the p53-associated factors p14ARF, p33ING1, p21WAF1 and MDM2.
    Tachibana M; Kawamata H; Fujimori T; Omotehara F; Horiuchi H; Ohkura Y; Igarashi S; Kotake K; Kubota K
    Int J Oncol; 2004 Oct; 25(4):913-20. PubMed ID: 15375540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative analysis of p53 expression and cell proliferation in gastric carcinomas. An immunohistochemical study.
    Gonda G; Bajtai A; Nagy P; Szántó I; Kiss J
    Hepatogastroenterology; 2004; 51(55):273-6. PubMed ID: 15011884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlation of 53BP1 and p53 polymorphisms to susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Cao YY; Ge H; Chen LQ; Chen ZF; Wen DG; Li Y; Zhang JH
    Ai Zheng; 2007 Oct; 26(10):1052-7. PubMed ID: 17927872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RT-PCR amplification of RNA extracted from formalin-fixed, paraffin-embedded oral cancer sections: analysis of p53 pathway.
    Tachibana M; Shinagawa Y; Kawamata H; Omotehara F; Horiuchi H; Ohkura Y; Kubota K; Imai Y; Fujibayashi T; Fujimori T
    Anticancer Res; 2003; 23(3C):2891-6. PubMed ID: 12926130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences of immunophenotypic markers and signaling molecules between adenocarcinomas of gastric cardia and distal stomach.
    Xue L; Zhang X; Li Y; Yang H; Li X; Mi J; Wang H; Wang J; Yan X
    Hum Pathol; 2011 Apr; 42(4):594-601. PubMed ID: 21146193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological features and prognosis of gastric cardia adenocarcinoma: a multi-institutional US study.
    Amini N; Spolverato G; Kim Y; Squires MH; Poultsides GA; Fields R; Schmidt C; Weber SM; Votanopoulos K; Maithel SK; Pawlik TM
    J Surg Oncol; 2015 Mar; 111(3):285-92. PubMed ID: 25308915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between p53 overexpression and gastric cancer progression.
    Kim JH; Uhm HD; Gong SJ; Shin DH; Choi JH; Lee HR; Noh SH; Kim BS; Cho JY; Rha SY; Yoo NC; Chung HC; Roh JK; Min JS; Lee KS; Kim BS
    Oncology; 1997; 54(2):166-70. PubMed ID: 9075790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53.
    Lindström MS; Klangby U; Wiman KG
    Oncogene; 2001 Apr; 20(17):2171-7. PubMed ID: 11360201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations of the p14ARF-p53-MDM2 pathway in oral squamous cell carcinoma: MDM2 overexpression is a common event.
    Lim KP; Sharifah H; Lau SH; Teo SH; Cheong SC
    Oncol Rep; 2005 Oct; 14(4):963-8. PubMed ID: 16142358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pokemon enhances proliferation, cell cycle progression and anti-apoptosis activity of colorectal cancer independently of p14ARF-MDM2-p53 pathway.
    Zhao Y; Yao YH; Li L; An WF; Chen HZ; Sun LP; Kang HX; Wang S; Hu XR
    Med Oncol; 2014 Dec; 31(12):288. PubMed ID: 25367850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo.
    Xirodimas D; Saville MK; Edling C; Lane DP; Laín S
    Oncogene; 2001 Aug; 20(36):4972-83. PubMed ID: 11526482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer.
    Agrawal A; Yang J; Murphy RF; Agrawal DK
    Exp Mol Pathol; 2006 Oct; 81(2):115-22. PubMed ID: 16919268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas.
    Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K
    J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.